[Trials with gabapentin monotherapy in patients with complex partial or secondary generalized seizures]

Praxis (Bern 1994). 1997 Sep 10;86(37):1430-1.
[Article in German]

Abstract

Neurontin (Gabapentin) is indicated as an add-on treatment of partial epileptic seizures. Clinical studies demonstrating the efficacy of Neurontin as monotherapy are currently on going. This article describes the design of 2 clinical trials of Gabapentin as monotherapy for epileptic seizures.

Publication types

  • Comparative Study

MeSH terms

  • Acetates / adverse effects
  • Acetates / therapeutic use*
  • Amines*
  • Anticonvulsants / adverse effects
  • Anticonvulsants / therapeutic use*
  • Cyclohexanecarboxylic Acids*
  • Dose-Response Relationship, Drug
  • Double-Blind Method
  • Drug Administration Schedule
  • Electroencephalography / drug effects
  • Epilepsies, Partial / drug therapy*
  • Epilepsy, Complex Partial / drug therapy*
  • Gabapentin
  • Humans
  • Randomized Controlled Trials as Topic
  • Research Design
  • Treatment Outcome
  • gamma-Aminobutyric Acid*

Substances

  • Acetates
  • Amines
  • Anticonvulsants
  • Cyclohexanecarboxylic Acids
  • gamma-Aminobutyric Acid
  • Gabapentin